by admin_63069 | Dec 2, 2024 | News You Can Use
The trial excluded patients with recent chemotherapy, immunotherapy, or major surgeries, ensuring a focused study population.
by admin_63069 | Nov 18, 2024 | News You Can Use
VA analysis finds men with limited life expectancy still getting aggressive treatment.
by admin_63069 | Oct 9, 2024 | News You Can Use
Patients with metastatic, castration-resistant prostate cancer saw significant benefits from the combination of Xofigo and Xtandi.
by admin_63069 | Oct 2, 2024 | News You Can Use
PPP nomograms accurately stratify high- vs. low-risk groups for overall survival in early and late stages of prostate cancer and yield better prediction than established clinical risk tools.
by admin_63069 | Sep 25, 2024 | News You Can Use
Activation of the MYC gene in prostate cancer leads to major changes in the surrounding microenvironment.
